Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07039591 · ClinicalTrials.gov registry record · Early Phase 1

Assess Performance Attributes and Acceptability of Non-medicated Intravaginal Rings Among Sexually Active Women in Atlanta, GA

A Early Phase 1 study of Contraceptive Usage, sponsored by Population Council.

Recruiting
Registry status
Early Phase 1
Development phase
60
Enrollment target
1
Study location

NCT07039591 is a Early Phase 1 study of Contraceptive Usage that is actively recruiting participants, run by Population Council. The registered enrollment target is 60 participants, below the 623-participant average among 11 other Contraceptive Usage trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07039591, a Early Phase 1 study of Contraceptive Usage, is actively recruiting participants, sponsored by Population Council.

RECRUITING
Registry status
Early Phase 1
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

A randomized open label crossover trial to assess performance attributes and acceptability of non-medicated intravaginal rings among sexually active women in Atlanta, GA

Conditions Studied

Interventions

  • DEVICE Pro-type IVR

Study Locations (1)

Georgia

  • Emory University - Atlanta

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-08-08
Est. Completion 2026-10-30
Phase Early Phase 1

Sponsor

Population Council

11 total trials

What the Registry Record Tells You About NCT07039591

The ClinicalTrials.gov registry entry for NCT07039591 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 623-participant average among 11 other Contraceptive Usage trials with a reported enrollment target (90% lower). The listed sponsor is Population Council, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Contraceptive Usage appearing as the primary indexed condition, and to 1 intervention - of which Pro-type IVR is the first listed.

NCT07039591 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT07039591 about?

NCT07039591 is a clinical study titled "Assess Performance Attributes and Acceptability of Non-medicated Intravaginal Rings Among Sexually Active Women in Atlanta, GA". A randomized open label crossover trial to assess performance attributes and acceptability of non-medicated intravaginal rings among sexually active women in Atlanta, GA

What is the current status of trial NCT07039591?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 60 participants. The study started on 2025-08-08. Estimated completion is 2026-10-30.

What conditions does trial NCT07039591 study?

This clinical trial studies the following conditions: Contraceptive Usage.

What interventions are being tested in trial NCT07039591?

The interventions under investigation include: Pro-type IVR (DEVICE).

Who is sponsoring clinical trial NCT07039591?

This trial is sponsored by Population Council, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07039591 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Contraceptive Usage

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.